1型糖尿病患者使用心脏保护辅助药物。

IF 3.8 3区医学 Q2 Medicine

Diabetes Therapy Pub Date : 2025-02-01 Epub Date: 2025-01-06 DOI:10.1007/s13300-024-01687-3

Jerry R Greenfield, Ruth Frampton, Kellie Millard, Jennifer R Snaith

引用次数: 0

摘要

即使考虑到包括血糖在内的传统心血管风险因素，1型糖尿病也与心血管风险过高有关。因此，迫切需要记录导致1型糖尿病心血管死亡率差距的代谢异常，并检查心脏保护型2型糖尿病药物是否可以预防该人群的过早发病和死亡。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Use of Cardioprotective Adjuncts in Type 1 Diabetes.

Type 1 diabetes is associated with excess cardiovascular risk, even after accounting for traditional cardiovascular risk factors, including glycaemia. Hence, there is an urgent need to document the metabolic abnormalities that contribute to the cardiovascular mortality gap in type 1 diabetes, and to examine whether cardioprotective type 2 diabetes medications prevent premature morbidity and mortality in this population.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Diabetes Therapy Medicine-Endocrinology, Diabetes and Metabolism

CiteScore

6.90

自引率

7.90%

发文量

130

审稿时长

6 weeks

期刊介绍： Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.